» Articles » PMID: 16782009

Mitotic Checkpoint Slippage in Humans Occurs Via Cyclin B Destruction in the Presence of an Active Checkpoint

Overview
Journal Curr Biol
Publisher Cell Press
Specialty Biology
Date 2006 Jun 20
PMID 16782009
Citations 278
Authors
Affiliations
Soon will be listed here.
Abstract

In the presence of unattached/weakly attached kinetochores, the spindle assembly checkpoint (SAC) delays exit from mitosis by preventing the anaphase-promoting complex (APC)-mediated proteolysis of cyclin B, a regulatory subunit of cyclin-dependent kinase 1 (Cdk1). Like all checkpoints, the SAC does not arrest cells permanently, and escape from mitosis in the presence of an unsatisfied SAC requires that cyclin B/Cdk1 activity be inhibited. In yeast , and likely Drosophila, this occurs through an "adaptation" process involving an inhibitory phosphorylation on Cdk1 and/or activation of a cyclin-dependent kinase inhibitor (Cdki). The mechanism that allows vertebrate cells to escape mitosis when the SAC cannot be satisfied is unknown. To explore this issue, we conducted fluorescence microscopy studies on rat kangaroo (PtK) and human (RPE1) cells dividing in the presence of nocodazole. We find that in the absence of microtubules (MTs), escape from mitosis occurs in the presence of an active SAC and requires cyclin B destruction. We also find that cyclin B is progressively destroyed during the block by a proteasome-dependent mechanism. Thus, vertebrate cells do not adapt to the SAC. Rather, our data suggest that in normal cells, the SAC cannot prevent a slow but continuous degradation of cyclin B that ultimately drives the cell out of mitosis.

Citing Articles

Role of spindle assembly checkpoint proteins in gametogenesis and embryogenesis.

Pun R, North B Front Cell Dev Biol. 2025; 12:1491394.

PMID: 39911185 PMC: 11794522. DOI: 10.3389/fcell.2024.1491394.


Kojic Acid Derivative as an Antimitotic Agent That Selectively Kills Tumour Cells.

Pichiri G, Piludu M, Congiu T, Grandi N, Coni P, Piras M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861074 PMC: 11768441. DOI: 10.3390/ph18010011.


IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an mA-dependent manner.

Xu J, Wang Y, Ren L, Li P, Liu P Genes Dis. 2024; 12(1):101214.

PMID: 39534570 PMC: 11554607. DOI: 10.1016/j.gendis.2024.101214.


Cyclin A/Cdk1 promotes chromosome alignment and timely mitotic progression.

Valles S, Bural S, Godek K, Compton D Mol Biol Cell. 2024; 35(11):ar141.

PMID: 39356777 PMC: 11617097. DOI: 10.1091/mbc.E23-12-0479.


Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer.

Calheiros-Lobo M, Silva J, Pinto B, Monteiro L, Silva P, Bousbaa H Pharmaceutics. 2024; 16(9).

PMID: 39339232 PMC: 11435222. DOI: 10.3390/pharmaceutics16091196.


References
1.
Sherwood S, Sheridan J, Schimke R . Induction of apoptosis by the anti-tubulin drug colcemid: relationship of mitotic checkpoint control to the induction of apoptosis in HeLa S3 cells. Exp Cell Res. 1994; 215(2):373-9. DOI: 10.1006/excr.1994.1354. View

2.
Rieder C, Schultz A, Cole R, Sluder G . Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J Cell Biol. 1994; 127(5):1301-10. PMC: 2120267. DOI: 10.1083/jcb.127.5.1301. View

3.
Andreassen P, Margolis R . Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J Cell Biol. 1994; 127(3):789-802. PMC: 2120226. DOI: 10.1083/jcb.127.3.789. View

4.
Rieder C, Palazzo R . Colcemid and the mitotic cycle. J Cell Sci. 1992; 102 ( Pt 3):387-92. DOI: 10.1242/jcs.102.3.387. View

5.
Melloy P, Holloway S . Changes in the localization of the Saccharomyces cerevisiae anaphase-promoting complex upon microtubule depolymerization and spindle checkpoint activation. Genetics. 2004; 167(3):1079-94. PMC: 1470941. DOI: 10.1534/genetics.103.025478. View